Marthalen, Switzerland

Thomas Ammann

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 42(Granted Patents)


Location History:

  • Seebestrass, CH (2003)
  • Marthalen, CH (1998 - 2022)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Thomas Ammann: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Ammann is a distinguished inventor based in Marthalen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work primarily focuses on the development of stable formulations and salts of important therapeutic compounds.

Latest Patents

Among his latest patents, Ammann has developed the hemisulfate salt of 5,10-methylene-(6R)-tetrahydrofolic acid. This invention is directed towards providing a stable crystalline form of the compound, along with pharmaceutical compositions and their applications in therapy, particularly in chemotherapy. Additionally, he has created stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt, which also have significant therapeutic uses.

Career Highlights

Throughout his career, Thomas Ammann has worked with notable companies such as Merck & Cie and Eprova AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective therapeutic solutions.

Collaborations

Ammann has collaborated with several professionals in his field, including Rudolf Moser and Viola Groehn. These partnerships have further enhanced his research and development efforts, leading to impactful advancements in pharmaceutical chemistry.

Conclusion

Thomas Ammann's innovative work in the pharmaceutical industry has led to significant advancements in therapeutic formulations. His contributions continue to influence the field and improve treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…